leisure time -WSS

leisure time

author：explore 2025-09-28 01:39:17 - browse：1

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

knowledge

WSS

ADCs take center stage as promising cancer treatments

How AI can help patients find reliable information about doctors

How AI can help patients find reliable information about doctors

J&J lung cancer data amount to new salvo against AstraZeneca

STAT Summit: How researchers deal with rejection

Amylyx ALS drug fails large clinical trial

entertainment

leisure time

hotspot

Peter Hotez and the public health issue of online harassment

IVF, abortion rights issues kick off Biden’s State of the Union

Virginia high school admissions case could be legal follow

Change Healthcare payments predicted restored March 15

Peter Hotez and the public health issue of online harassment

How to bring more disabled researchers into academia

Medical records are filled with copy

The drug industry has found itself all alone in Washington

Peter Hotez and the public health issue of online harassment

Why a market frenzy over new weight loss drugs defies logic

hotspot

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Smaller biotechs seek to piggyback on weight loss drug boom

Merck, Daiichi strike cancer drug pact worth up to $22 billion

A deep dive into Applied Therapeutics’ data, and questions on Cassava

IVF, abortion rights issues kick off Biden’s State of the Union

STAT Summit: The economic case for universal basic health care

knowledge

leisure time

focus

focus